CAD 0.23
(-4.17%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 13.99 Million CAD | -1.14% |
2022 | 14.16 Million CAD | -8.01% |
2021 | 15.39 Million CAD | -5.25% |
2020 | 16.24 Million CAD | 6.26% |
2019 | 15.28 Million CAD | 748.74% |
2018 | 1.8 Million CAD | 41.13% |
2017 | 1.27 Million CAD | 939.73% |
2016 | 122.76 Thousand CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 11.4 Million CAD | -16.52% |
2024 Q1 | 13.66 Million CAD | -2.39% |
2023 Q4 | 13.99 Million CAD | -29.18% |
2023 FY | 13.99 Million CAD | -1.14% |
2023 Q3 | 19.76 Million CAD | 17.35% |
2023 Q2 | 16.84 Million CAD | 29.99% |
2023 Q1 | 12.95 Million CAD | -8.49% |
2022 Q1 | 15.89 Million CAD | 3.24% |
2022 FY | 14.16 Million CAD | -8.01% |
2022 Q4 | 14.16 Million CAD | 6.96% |
2022 Q3 | 13.23 Million CAD | -6.56% |
2022 Q2 | 14.16 Million CAD | -10.84% |
2021 Q3 | 16.52 Million CAD | 18.86% |
2021 FY | 15.39 Million CAD | -5.25% |
2021 Q2 | 13.9 Million CAD | -2.98% |
2021 Q1 | 14.33 Million CAD | -11.77% |
2021 Q4 | 15.39 Million CAD | -6.87% |
2020 Q2 | 15.19 Million CAD | -1.5% |
2020 FY | 16.24 Million CAD | 6.26% |
2020 Q1 | 15.42 Million CAD | 0.91% |
2020 Q4 | 16.24 Million CAD | 0.34% |
2020 Q3 | 16.19 Million CAD | 6.55% |
2019 Q2 | 5.32 Million CAD | 20.0% |
2019 FY | 15.28 Million CAD | 748.74% |
2019 Q1 | 4.43 Million CAD | 146.43% |
2019 Q3 | 6.83 Million CAD | 28.29% |
2019 Q4 | 15.28 Million CAD | 123.72% |
2018 Q1 | - CAD | -100.0% |
2018 Q4 | 1.8 Million CAD | -12.02% |
2018 Q3 | 2.04 Million CAD | 0.0% |
2018 FY | 1.8 Million CAD | 41.13% |
2017 FY | 1.27 Million CAD | 939.73% |
2017 Q4 | 1.27 Million CAD | 0.0% |
2016 FY | 122.76 Thousand CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aurora Cannabis Inc. | 236.8 Million CAD | 94.088% |
Avant Brands Inc. | 33.22 Million CAD | 57.865% |
Cardiol Therapeutics Inc. | 8.45 Million CAD | -65.59% |
Crescita Therapeutics Inc. | 5.77 Million CAD | -142.365% |
Knight Therapeutics Inc. | 198.62 Million CAD | 92.952% |
MediPharm Labs Corp. | 10.93 Million CAD | -28.055% |
OrganiGram Holdings Inc. | 26.83 Million CAD | 47.827% |
Canopy Growth Corporation | 799.82 Million CAD | 98.25% |
Willow Biosciences Inc. | 3.23 Million CAD | -332.468% |
Auxly Cannabis Group Inc. | 210.85 Million CAD | 93.361% |